Table 2.
Characteristic | Subjects without VTE | Subjects with VTE | OR | p value |
---|---|---|---|---|
N=67099 | N=2656 | |||
Age, Mean±SD | 60.5±17.0 | 69.5±13.4 | 1.04 [1.04;1.04] | <0.001 |
Gender: | ||||
Female | 51507 (76.8%) | 2185 (82.3%) | Ref. | Ref. |
Male | 15592 (23.2%) | 471 (17.7%) | 0.71 [0.64;0.79] | <0.001 |
BMI, Mean±SD | 28.0±6.51 | 30.3±6.27 | 1.05 [1.04;1.06] | <0.001 |
SES: | ||||
Low | 26141 (39.1%) | 1021 (38.6%) | Ref. | Ref. |
Medium | 26565 (39.7%) | 1082 (40.9%) | 1.04 [0.96;1.14] | 0.346 |
High | 14228 (21.3%) | 544 (20.6%) | 0.98 [0.88;1.09] | 0.695 |
RA | 10967 (16.3%) | 815 (30.7%) | 2.27 [2.08;2.47] | <0.001 |
Smoking | 19788 (29.5%) | 748 (28.2%) | 0.94 [0.86;1.02] | 0.140 |
CRP, Mean±SD | 1.03±1.77 | 1.32±2.16 | 1.07 [1.05;1.09] | <0.001 |
SD: Standard deviation; BMI: Body mass index, kg/m2; SES: Socioeconomic status; CRP (years 2002–2013), reference range: 0–0.5 mg/dL; VTE: Venous thromboembolism, defined as DVT, PE or both.